The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTekCapital Regulatory News (TEK)

Share Price Information for TekCapital (TEK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 8.75
Bid: 8.50
Ask: 9.00
Change: 0.81 (10.20%)
Spread: 0.50 (5.882%)
Open: 8.25
High: 8.75
Low: 8.25
Prev. Close: 7.94
TEK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Report

31 Jul 2017 07:00

RNS Number : 5075M
Tekcapital plc
31 July 2017
 

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR"). With the publication of this announcement via a Regulatory Information Service ("RIS"), this inside information is now considered to be in the public domain.

 

31 July 2017

Tekcapital plc

("Tekcapital", "the Company" or "the Group")

 

Half Yearly Report

for the period ended 31 May 2017

 

Tekcapital plc (AIM: TEK), a UK intellectual property (IP) investment group focused on creating marketplace value from university technology, announces its results for the six month period ended 31 May 2017.

 

HIGHLIGHTS

 

Financial

· Total revenue of $3,806,178 (H1 2016: $247,262), the increase reflecting primarily an unrealised gain on revaluation of our investment in Belluscura and an increase in sales

· Revenue from services increased 157% to $635,329 (H1 2016: $247,262)

· Profit before tax of $1,554,796 (H1 2016: loss of $997,174), reflecting substantially increased revenues

· Basic earnings per share after tax of $0.04 (30 November 2016: loss per share of $0.06)

· Net assets per share increased to $0.19 as at 31 May 2017 (30 November 2016: $0.06)

· Fair value of the portfolio at 31 May 2017 of $4,148,349 (November 2016: $0)

· Adoption of a new IFRS accounting policy to fair value our investments, consistent with our refined business purpose to that of investing in and commercialising university intellectual properties as well as providing intellectual property investment services and advice to create market value

· During the period, Tekcapital successfully concluded a fundraising of approximately $3 million, before expenses, which was oversubscribed

 

Portfolio company activity/progress/highlights

· Notice of Allowance received for Piezoelectric Vibrational Energy Harvester Patent Application

· Successful production and independent testing of µSalt®

· Our portfolio company, Belluscura Ltd, successfully concluded a private placement of approximately US$1.7m

· Development and launch of new software App on both iOS and Google Play to search global university IP

· Out licensed air-conditioning technology to Wecast Technology Group

· Acquisition of new Gesture Recognition Technology (Trace-itTM) from the University of Central Florida

 

 

Dr. Clifford Gross, Chairman commented: 

"We are pleased to report successful half-year performance for the Group. We have seen a significant increase in total revenue to $3,806,178, largely due to an unrealised profit on the revaluation of investments in portfolio companies, which has resulted in net income after tax of $1,553,390. We have also seen a 153% increase in net assets to $7,974,906 on a year on year basis. We believe our unique approach of acquiring and commercialising university IP innovations, coupled with providing a range of IP value creation services to universities and corporates, has uniquely positioned us to create market value from university discoveries more efficiently than traditional IP investment companies."

 

Contacts

 

Tekcapital Plc

Clifford M. Gross, Ph.D. info@tekcapital.com

 

Allenby Capital Limited (AIM Nominated Adviser & Joint Broker) +44 (0) 20 3328 5656

Jeremy Porter / Alex Brearley

 

Dowgate Capital Stockbrokers (Joint Broker) +44 (0) 1293 517744

David Poutney / James Serjeant

 

Walbrook PR Ltd +44 (0) 20 7933 8780

Paul Cornelius / Helen Cresswell / Sam Allen tekcapital@walbrookpr.com

Tekcapital plc - The World's Largest University Network for Open Innovation

Tekcapital's objective is to create value from investing in new, university-developed intellectual properties (IP). Additionally, using its proprietary discovery search engine, linked to 4,500+ universities in 160 countries, coupled with expert scientific review, Tekcapital provides a range of IP investment services to make it easy for organisations to find and acquire the IP, analytics and technology transfer professionals they need to create a competitive advantage. Tekcapital plc is quoted on the AIM market of the London Stock Exchange (AIM: symbol TEK) and is headquartered in Oxford, in the UK. For more information, please visit www.tekcapital.com

 

LEI: 213800GOJTOV19FIFZ85

CHAIRMAN'S STATEMENT

 

Summary

 

Tekcapital creates marketplace and shareholder value by:

 

· Having one of the world's largest networks of university suppliers, spanning more than 4,500 institutions across 160 countries, mitigates adverse selection and dramatically enhances finding valuable IP opportunities to invest in

· Using this network, to acquire a portfolio of proprietary university IP, for subsequent out-licensing to firms that can directly commercialise these innovations

· Providing IP investment services to our university network to assist them in bringing their innovations directly to leading companies worldwide. This provides the dual benefit of building durable relationships with our IP suppliers while simultaneously generating revenue

· Additionally, providing IP investment services to our corporate partners to help them cost-effectively address the 'quickening pace of innovation' with new university-developed IP.

Review of the Business

Tekcapital is passionate about creating value from university intellectual property ("IP"). During the past half-year we believe that we have made good progress.

Tekcapital has refined its business purpose to that of investing in and commercialising university intellectual properties as well as continuing to provide intellectual property investment services and advice to create market value. This refined focus includes creating value through out-licensing of intellectual properties and, in some cases, from the monetisation of portfolio company investments through trade sales or Initial Public Offerings ("IPOs"), when appropriate. The Board envisages that Tekcapital's shareholder returns will be derived primarily from mid to long-term capital appreciation of a portion of its intellectual property investments, as well as from providing IP investment services to clients. In addition, the Group has, and when appropriate intends to, receive shares in its clients and portfolio companies as payment for the services provided.

The Group's technology out-licensing service leverages its competencies to identify, review and acquire particularly promising IP which management believes can be readily out-licensed to commercial corporations. This service extends the Group's impact by directly commercialising innovative university and corporate developed technologies and also has the potential to capture for the Group's own benefit more of the value realised when innovative ideas are successfully commercialised. Since inception two years ago, this new effort has grown rapidly. As of the date of this report we have secured exclusive licenses to 59 patents, applications and industrial designs, including those held by Belluscura.

We believe that there is a significant value to be realised from the patent rights that we have acquired to-date, and we are strategically moving forward with our commercialisation efforts, including seeking to out-license our IP. As such, Tekcapital's IP search and technology transfer investment services represent intellectual property advisory services, and the Group continues to provide ongoing assistance to its portfolio companies. During the period, the Group reported the following portfolio company operational highlights:

· Notice of Allowance received for Piezoelectric Vibrational Energy Harvester Patent Application which enhances our IP position for the in-shoe energy harvesting technology

· Successful production and independent testing of µSalt® which enables the independent comparison of uSalt's competitive advantage vs. traditionally salted snack foods

· Our portfolio company, Belluscura Ltd, successfully concluded a private placement of approximately US$1.7m, demonstrating good progress on executing their business plan

· Development and launch of new software App on both iOS and Google Play to search global university IP (http://tekcapital.com/app/)

· Out licensed air-conditioning technology to Wecast Technology Group

· Acquisition of new Gesture Recognition Technology (Trace-itTM) from the University of Central Florida which the directors of Tekcapital believe makes it possible to improve the accuracy and the speed of gesture recognizers and is compatible with existing recognition systems on any device.

 

Our investment in Belluscura continues to develop and is a good indication of how we are able to utilize intellectual property acquisition. Belluscura has recently launched a number of products in both the US and UK and has acquired the rights to a portfolio of oxygen concentrator patents and know-how, which Belluscura is seeking to develop into a commercial product during 2017 and 2018.

In January 2017, Tekcapital completed a placing of 6,968,500 new ordinary shares at a price of 35 pence per share to raise a total of approximately US$3.0 million before expenses.

On 3 May 2017, we were pleased to have also announced a private placement into Belluscura, of approximately US$1.7 million. This has reduced Tekcapital's ownership interest in Belluscura to 48%. Further, as previously announced, Belluscura is exploring an IPO in 2017.

Financial Review

While the Group is still in its early stages of development, we are encouraged with the growth in revenues from both services and the unrealised appreciation of portfolio investments. Total revenue increased to $3,806,178 (H1 2016: $247,262) and profit after tax increased to $1,553,390 (H1 2016: loss of $997,174) both reflecting the unrealised gain in our investment in Belluscura of $2,944,193 and the increase in technology transfer service sales.

 

The Group's net assets stood at US$7,974,906 as at the end of the period. The Group's total liabilities of US$596,308 as at the end of the period are relatively low as its costs have been settled without delay using available funds. Further, the Group has no debt.

The fair value of the portfolio at 31 May 2017 of $4,148,349 (November 2016: $0), primarily made up of Belluscura plus several early-stage portfolio companies.

 

During the period we adopted a new accounting policy to hold our investment in portfolio companies at fair value, consistent with our refined business focus of investing in and commercialising university intellectual properties as well as providing intellectual property investment services and advice to create market value. This refined focus includes creating value through out-licensing of intellectual properties and in some cases from the monetisation of portfolio company investments through trade sales or Initial Public Offerings, when appropriate. The change in the accounting policy was implemented to better align with this refined business focus and to adhere to the requirements of IFRS 10, as documented in the Note 3 "Accounting Policies".

 

 

Current Trading and Outlook

Having continued to develop and refine the Group's existing business, the Directors remain confident that continued investment in university IP and providing services to create market value from this IP remains the right policy.

Tekcapital has observed that, over time, and in any market, competition tends to reduce a company's competitive advantage and erode its returns on invested capital. Tekcapital's IP investments available for license and the IP services the Group provides are designed to help address this problem.

The Directors are confident that increases in net assets will arise from gains in the Group's portfolio and service revenue in future periods. The Group continues its sharp focus on the near-term consummation of out-licenses for its portfolio of IP. With an increasing number of companies making ever faster and more disruptive use of innovative ideas sourced exogenously, and with patented university and corporate technologies an increasingly valued currency, the market opportunity for the Group is large and should continue to grow apace.

Clifford M. Gross, Ph.D.

Executive Chairman

 

31 July 2017

 

 

 

 

 

CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

 

For the six months ended 31 May 2017

 

Notes

Six months ended 31 May 2017

Six months ended 31 May 2016

Year ended 30 November

 2016

Unaudited

Unaudited

Audited

US$

US$

US$

 

Revenue

Revenue from services

635,329

247,262

764,777

Other operating income

Unrealised profit on the revaluation of investments

7

2,944,193

-

-

Profit/(Loss) on derecognition of subsidiary

226,656

-

-

Total revenue

3,806,178

247,262

764,777

Cost of sales

(502,618)

-

(456,482)

Gross profit

3,303,560

247,262

308,295

Other administrative expenses

(1,748,764)

(1,244,749)

(2,866,807)

Operating profit/(loss)

1,554,796

(997,487)

(2,558,512)

Finance income

-

313

314

Profit/(Loss) before taxation

1,554,796

(997,174)

(2,558,198)

Income tax expense

4

(1,406)

-

(766)

Profit/(Loss) after taxation

1,553,390

(997,174)

(2,558,964)

Other comprehensive income

Currency translation difference

359,983

(4,966)

(160,451)

Total comprehensive profit/(loss)

1,913,373

(1,002,140)

(2,719,415)

 

Profit/(Loss) attributable to:

Equity holders of the parent

1,785,585

(990,204)

(2,215,032)

Non-controlling interests

(232,195)

(6,970)

(343,932)

1,553,390

(997,174)

(2,558,964)

Total comprehensive profit/(loss) attributable to:

Equity holders of the parent

2,041,863

(995,170)

(2,302,423)

Non-controlling interests

(128,490)

(6,970)

(416,992)

1,913,373

(1,002,140)

(2,719,415)

Profit/(Loss) per share

5

Basic earnings per share

0.044

(0.028)

(0.063)

Diluted earnings per share

0.043

(0.028)

(0.063)

 

 

 

 

CONSOLIDATED STATEMENT OF FINANCIAL POSITION

 

At 31 May 2017

 

Notes

As at 31

May 2017

As at 31

 May 2016

As at 30 November 2016

Unaudited

Unaudited

Audited

US$

US$

US$

Assets

Non-current assets

Intangible assets

6

841,727

1,387,470

1,409,758

Financial assets at fair value through profit and loss

7

4,148,349

-

-

Property, plant and equipment

4,624

60,475

51,490

4,994,700

1,447,945

1,461,248

Current Assets

Trade and other receivables

440,711

134,138

316,545

Inventory

-

-

4,503

Cash and cash equivalents

3,135,803

1,937,595

1,839,603

3,576,514

2,071,733

2,160,651

Total Assets

8,571,214

3,519,678

3,621,899

Liabilities

Current liabilities

Trade and other payables

595,808

361,924

484,325

Current income tax liabilities

500

500

500

Loans and borrowings

-

-

-

Total liabilities

596,308

362,424

484,825

 

Net Assets

 

 

7,974,906

 

3,154,591

 

2,715,674

Equity

Share capital

8

264,221

228,052

228,052

Share premium

8

9,271,098

6,377,383

6,377,383

Retained earnings

(1,704,982)

(3,421,560)

(3,778,052)

Translation reserve

216,738

42,885

(39,540)

Merger reserve

(72,169)

(72,169)

(72,169)

Total equity attributable to equity holders of the parent

7,974,906

3,154,591

2,715,674

Non-controlling interests

-

2,663

421,400

Total Equity and Liabilities

8,571,214

3,519,678

3,621,899

 

 

 

CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

 

For the six months ended 31 May 2017

 

Attributable to equity holders of the parent

 

Share capital

Share Premium

Translation Reserve

Merger Reserve

Retained Earnings

Total

Non-controlling interest

Total Equity

US$

US$

US$

US$

US$

US$

US$

US$

Unaudited

Balance at 1 December 2016

228,052

6,377,383

(39,540)

(72,169)

(3,778,052)

2,715,674

421,400

3,137,074

Comprehensive income

Profit for the period

-

-

-

-

1,785,585

1,785,585

(232,195)

1,553,390

Other comprehensive income

-

-

256,278

-

-

256,278

103,705

359,983

Share based payments

-

-

-

-

31,868

31,868

-

31,868

Issue of ordinary shares

34,879

2,814,385

-

-

-

2,849,264

-

2,849,264

Warrants exercised

1,290

79,330

-

-

-

80,620

-

80,620

New funds into non-controlling interest

-

-

-

-

-

-

323,300

323,300

(Loss)/Gain arising from change in non-controlling interest

-

-

-

-

255,617

255,617

(255,617)

-

Elimination of NCI as a result of change in the accounting policy

-

-

-

-

-

-

(360,593)

(360,593)

Balance at 31 May 2017

264,221

9,271,098

216,738

(72,169)

(1,704,982)

7,974,906

-

7,974,906

Unaudited

Balance at 1 December 2015

224,684

5,980,751

47,851

(72,169)

(2,461,900)

3,719,217

-

3,719,217

Loss for the period

-

-

-

-

(990,204)

(990,204)

(6,970)

(997,174)

Other comprehensive income

-

-

(4,966)

-

-

(4,966)

-

(4,966)

Issue of Ordinary Shares

3,368

396,632

-

-

-

400,000

-

400,000

Share based payments

-

-

-

-

36,577

36,577

-

36,577

New funds into non-controlling interest

-

-

-

-

-

-

3,600

3,600

Gain/Loss arising from change in non-controlling interests

-

-

-

-

(6,033)

(6,033)

6,033

-

Balance at 31 May 2016

228,052

6,377,383

42,885

(72,169)

(3,421,560)

3,154,591

2,663

3,157,254

 

 

 

 

 

 

 

 

Share capital

Share Premium

Translation Reserve

Merger Reserve

Retained Earnings

Total

Non-controlling interest

Total Equity

 

Audited

US$

US$

US$

US$

US$

US$

US$

US$

Balance at 1 December 2015

224,684

5,980,751

47,851

(72,169)

(2,461,900)

3,719,217

-

3,719,217

Loss for the period

-

-

-

-

(2,215,032)

(2,215,032)

(343,932)

(2,558,964)

Other comprehensive income

-

-

(87,391)

-

-

(87,391)

(73,060)

(160,451)

Share based payments

-

-

-

-

84,618

84,618

-

84,618

Issue of ordinary shares

3,368

396,632

-

-

-

400,000

-

400,000

New funds into non-controlling interest

-

-

-

-

-

-

1,652,654

1,652,654

Gain/Loss arising from change in non-controlling interests

-

-

-

-

814,262

814,262

(814,262)

-

Balance at 30 November 2016

228,052

6,377,383

(39,540)

(72,169)

(3,778,052)

2,715,674

421,400

3,137,074

 

 

Share capital represents the amount subscribed for share capital at nominal value.

 

Share premium represents the amount subscribed for share capital in excess of nominal value and net of any directly attributable issue costs.

 

The merger reserve arose on the share for share exchange undertaken by the Company with Tekcapital Europe Limited on 18 February 2014.

 

 

 

 

 

 

CONSOLIDATED STATEMENT OF CASH FLOWS

 

For the six months ended 31 May 2017

 

 

 

Group

 

 

Note

Six months

 ended

 31 May 2017

For the year ended

 31 May 2016

For the year ended

 30 Nov 2016

US $

US $

US $

Cash flows from operating activities

Cash used in operations

(1,363,134)

(851,457)

(2,376,124)

Taxation paid

(1,406)

(800)

(1,566)

Net cash used in operating activities

(1,364,540)

(852,257)

(2,377,690)

Cash flows from investing activities

Cash eliminated on derecognition of subsidiary

(596,176)

-

-

Purchases of property, plant and equipment

(3,733)

(54,632)

(55,359)

Purchases of intangible assets

(43,132)

(295,075)

(380,938)

Interest received

-

313

314

Net cash used in investing activities

(643,041)

(349,394)

(435,983)

Cash flows from financing activities

Proceeds from issuance of ordinary shares

3,051,889

-

-

Costs of raising finance

(202,625)

-

-

Proceeds from the exercise of warrants

80,620

-

-

Cash from non-controlling interest

323,300

-

1,652,654

Net cash from financing activities

3,253,184

-

1,652,654

Net (decrease)/increase in cash and cash equivalents

1,245,603

(1,201,651)

(1,161,019)

Cash and cash equivalents at beginning of year

1,839,603

3,139,246

3,139,246

Exchange gain/(loss) on cash and cash equivalents

50,597

-

(138,624)

Cash and cash equivalents at end of year

3,135,803

1,937,595

1,839,603

 

 

 

 

Notes to the financial information

 

1. General information

Tekcapital PLC is a company incorporated in England and Wales in 2014 and domiciled in the UK. The Company's registered office is at 5 Fleet Place, London, EC4M 7RD. The nature of the Company's operations and its principal activities are to act as the holding company of a group of companies engaged in international technology and intellectual property investment services.

 

2. Basis of preparation

The financial information for the six months ended 31 May 2017 set out in this interim financial information is unaudited and does not constitute statutory financial statements.

 

The interim condensed financial information has been presented in US Dollars ("$").

 

3. Accounting policies

The accounting policies applied by the Group in these unaudited half year results are consistent with those applied in the annual financial statements for the year ended 30 November 2016 with the exception of the recognition of the Group as an investment entity effective 1 May 2017.

 

Effective 1 May 2017, the Group adopted a change in the accounting policy triggered by classification of Tekcapital PLC as an investment entity under IFRS 10 paragraph 27. This determination resulted from analysis of the following key criteria provided under IFRS 10. An investment entity:

 

· Obtains funds from one or more investors for the purpose of providing clients with investment management services

· Commits to its investors that its business purpose is to invest funds solely for return from capital appreciation, investment income or both

· Measures and evaluate the performance of substantially all of its investments on a fair value basis.

 

The Board considers that the criteria are met in the Group's current circumstances.

 

Tekcapital has refined its business purpose to that of investing in and commercialising university intellectual properties as well as providing intellectual property investment services and advice to create market value. This refined focus includes creating value through out-licensing of intellectual properties and in some cases from the monetisation of portfolio company investments through trade sales or Initial Public Offerings, when appropriate. The Board envisages that Tekcapital's shareholder returns will derive primarily from mid to long-term capital appreciation of a portion of its intellectual property investments, as well as from providing IP investment services to clients. In addition, the Group has and when appropriate intends to receive shares in its clients and portfolio companies as payment for the services provided.

 

Following the adoption of the change in the accounting for its investments, Tekcapital discontinued consolidation of Belluscura and its other Intellectual Property portfolio investments effective 1 May 2017. Consequently, assets and liabilities of the investments were eliminated from the Group's balance sheet as of 1 May 2017.

 

Tekcapital's IP search and technology transfer investment services represent intellectual property advisory services, and therefore Tekcapital Europe Limited and Tekcapital LLC continue to be treated as subsidiaries and consolidated in the Group financial statements. These services may be provided to investors, clients and third parties.

 

The Group now measures its investments at fair value through profit or loss in accordance with IFRS 9. The Group uses valuation techniques appropriate in the circumstances and for which sufficient data are available to measure fair value, maximising the use of relevant observable inputs and minimising the use of unobservable inputs. Our newly adopted fair value valuation policy is as follows:

 

· The fair value of new portfolio companies is estimated at the cost of the acquired IP or equity plus associated expenses to facilitate the acquisition.

· Existing portfolio companies are valued as follows:

Ø If a market transaction such as third-party funding has occurred during the past 18 months we will value our ownership in the portfolio company at this observed valuation, absent any observed material changes during the period.

Ø In the absence of a recent market transaction, fair value will be estimated by alternative methods and where appropriate by an external, qualified valuation expert.

 

In accordance with this change, previously consolidated subsidiaries were deconsolidated at a gain to the group of $226,656. The group then recognised a fair value increase of $2,944,193 in relation to the investee companies which was based on the value implied by the private placement into Belluscura at 51 pence per share as announced on the 3 May 2017.

 

The principal accounting policies used in preparing the interim results are those the Group expects to apply in its financial statements for the year ending 30 November 2017.

 

4. Taxation

Immaterial charge of $1,406 has arisen in the six-month period ended 31 May 2017 (31 May 2016: $nil).

 

5. Earnings per share

Basic earnings per share is calculated by dividing the earnings attributable to ordinary shareholders by the weighted average number of Ordinary Shares outstanding during the period.

 

Diluted earnings per share is calculated by dividing the earnings attributable to ordinary shareholders by the sum of weighted average number of (1) Ordinary Shares outstanding during the period and (2) Ordinary Shares to be issued assuming exercise of outstanding stock options with intrinsic value above $0 at 31 May 2017.

 

 

Six months ended 31 May 2017

Six months ended 31 May 2016

Year ended 30 November 2016

US$

US$

US$

Profits/(Losses) attributable to equity holders of the Company

1,785,585

(997,174)

(2,215,032)

Weighted average number of Ordinary Shares in issue:

 

Basic

41,001,118

34,948,117

35,185,310

Diluted

41,264,580

34,948,117

35,185,310

Basic profit (loss) per share ($)

0.044

(0.028)

(0.063)

Diluted profit (loss) per share ($)

0.043

(0.028)

(0.063)

 

 

6. Intangible Assets

 

Purchased intangible assets

 

Licenses

US $

Website development

US $

Vortechs

US $

Invention Evaluator

US $

 

Total

US $

Costs

At 1 December 2015

378,228

33,306

-

323,735

735,269

Additions during the period

190,800

-

500,000

7,875

698,675

At 31 May 2016

569,028

33,306

500,000

331,610

1,433,944

At 1 December 2015

378,228

33,306

-

323,735

735,269

Additions during the period

270,858

-

500,000

10,080

780,938

Foreign currency translation

(27,215)

(7,304)

-

-

(34,519)

At 30 November 2016

621,871

26,002

500,000

333,815

1,481,688

 

Additions during the period

35,973

 

-

 

-

 

7,159

 

43,132

De-recognition due to the change in the accounting policy

(657,843)

 

-

 

-

 

-

 

(657,843)

At 31 May 2017

-

26,002

500,000

340,974

866,976

Accumulated amortisation and impairment

At 1 December 2015

(12,467)

(14,225)

-

-

(26,692)

Amortisation for the period

(14,790)

(4,992)

-

-

(4,992)

At 31 May 2016

(27,257)

(19,217)

-

-

(31,684)

As 1 December 2015

(12,467)

(14,225)

-

-

(26,692)

Amortisation for the period

(39,915)

(9,460)

-

-

(49,375)

Foreign currency translation

601

3,536

-

-

4,137

At 30 November 2016

(51,781)

(20,149)

-

-

(71,930)

 

At 1 December 2016

 

(51,781)

 

(20,149)

 

-

 

-

 

(71,930)

Amortisation for the period

(20,955)

(4,370)

-

-

(25,325)

De-recognition due to the change in the accounting policy

72,736

 

-

 

-

 

-

 

72,736

Foreign currency translation

-

(730)

-

-

(730)

At 31 May 2017

-

(25,249)

-

-

(25,249)

Net book value

At 31 May 2016

541,771

14,089

500,000

331,610

1,387,470

At 30 November 2016

570,088

5,853

500,000

333,815

1,409,756

At 31 May 2017

-

753

500,000

340,974

841,727

 

 

7. Financial Assets at Fair Value through Profit or Loss

 

Group's investments into portfolio companies are listed below:

 

1 December 2016

Additions

Fair value increase

31 May 2017

US $

US $

US $

US $

Belluscura Limited

-

731,930

2,944,193

3,676,123

Non Invasive Glucose Tek Limited

-

24,657

-

24,657

Ocutek Limited

-

183,030

-

183,030

Smart Food Tek Limited

-

47,365

-

47,365

eGravitas Limited

-

150,024

-

150,024

Frigidus Limited

-

52,500

-

52,500

eSoma Limited

-

-

-

-

Salarius Limited

-

14,650

-

14,650

Total Balance

-

1,204,156

2,944,193

4,148,349

 

 

A fair value increase of $2,944,193 was recorded based on the value implied by the private placement into Belluscura at 51 pence per share as announced on the 3 May 2017.

 

Given their early, pre-commercialisation stage of development, the other companies in the Group's portfolio are currently valued at cost of the acquired intellectual property plus associated expenses. Management anticipates employing an external, qualified valuation expert or apply an implied valuation based on a recent observable event or market transaction, following future commercialisation of the intellectual properties held by the Group's portfolio companies.

 

This is the only category of financial instruments measured and re-measured at fair value through profit and loss and arises as a result of a change in accounting policy in the current period. The valuation technique used falls under Level 3- Other techniques as defined by IFRS 7. There is no comparative amount and there has been no transfer between levels during the period.

 

8. Share Capital

 

The Company's ordinary shares are of £0.004 par value.

 

All the Company's issued ordinary shares have full voting, dividend and capital distribution (including winding up) rights; they do not confer any rights of redemption. The Company does not hold any ordinary shares in treasury.

 

Issued and fully paid

Shares

Share capital

Share premium

 

Number

US$

US$

 

Ordinary shares of £0.004 each

 

 

At 1 December 2015

34,843,339

224,684

5,980,751

 

Shares issued for the acquisition of Vortechs Group

577,868

3,368

396,632

 

 

As at 31 May 2016

35,421,207

228,052

6,377,383

 

 

At 1 December 2015

34,843,339

224,684

5,980,751

 

Shares issued for the acquisition of Vortechs Group

577,868

3,368

396,632

 

 

As at 30 November 2016

35,421,207

228,052

6,377,383

 

 

Shares issued in further public offering

6,968,500

34,879

2,814,385

 

Shares issued on exercise of warrants

265,000

1,290

79,330

 

 

As at 31 May 2017

42,654,707

264,221

9,271,098

 

 

 

9. Related party transactions

The Group has taken advantage of the exemption in IAS 24 "related parties" not to disclose transactions with other Group companies. During the period the Group did not employ any services of non-Group companies meeting the definition of related parties.

 

 

10. Events after the reporting period

There were no material events subsequent to the reporting period.

 

11. Interim results

The interim results for the six months ended 31 May 2017 will not be sent to shareholders but will be available from the Company's website at http://tekcapital.com/investors/.

 

- Ends -

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR RMMLTMBIJBJR
Date   Source Headline
2nd May 20247:00 amRNSPortfolio Company Update Guident Q1 2024
26th Apr 20247:00 amRNSInnovative Eyewear Canadian Partnership
25th Apr 20247:00 amRNSInnovative Eyewear Patent Filings
18th Apr 20247:00 amRNSInnovative Eyewear Signs Brand Ambassador
17th Apr 20247:00 amRNSInnovative Eyewear Distribution Partnership
9th Apr 20247:00 amRNSPortfolio Company Update : Guident Ltd
5th Apr 20247:00 amRNSPortfolio Company Update : Guident Ltd
28th Mar 202410:20 amRNSNotification of Major Holdings
7th Mar 202411:15 amRNSNotification of Major Holdings
6th Mar 20247:00 amRNSIntellectual Property Update
29th Feb 20247:51 amRNSFundraising of £2.0 million
19th Feb 20247:00 amRNSPortfolio Company Update : Guident Ltd
15th Feb 202410:31 amRNSNotification of Major Holdings
15th Feb 20247:00 amRNSGuident Expands its Strategic Partnership
13th Feb 20242:24 pmRNSNotification of Major Holdings
1st Feb 20247:15 amRNSMicroSalt Admission to AIM First Day of Dealings
1st Feb 20247:01 amRNSNotice of Presentation on Investor Meet Company
24th Jan 20247:00 amRNSBellescura Plc - Disposal of Shares
12th Jan 20244:31 pmRNSLoan Agreement with Innovative Eyewear Inc
11th Jan 20247:00 amRNSInnovative Eyewear Patent Applications
9th Jan 20247:00 amRNSMicroSalt expand Placement Low Sodium Salt Shakers
22nd Dec 20237:00 amRNSAnnual Corporate & Strategy Update
14th Dec 20237:00 amRNSInnovative Eyewear Appoints Brand Ambassador
13th Dec 20237:00 amRNSInnovative Eyewear Update for Android ChatGPT App
12th Dec 20237:00 amRNSInnovative Eyewear,Inc. Global Licensing Agreement
17th Nov 20237:00 amRNSInnovative Eyewear Launches Upgraded Charging Dock
16th Nov 202312:12 pmRNSForm 8.3 - Belluscura PLC
1st Nov 20237:00 amRNSMicroSalt placement SaltMe! Crisps in MR Williams
19th Oct 20237:00 amRNSMicroSalt placement of SaltMe Low Sodium Crisps
17th Oct 20237:00 amRNSInnovative Eyewear Launches New Collection
16th Oct 20237:00 amRNSTakeover Code Form 8.3 - Belluscura plc
5th Oct 20237:00 amRNSBelluscura Update
5th Oct 20237:00 amRNSNotification of Major Holdings
3rd Oct 20238:00 amRNSMicroSalt Primary Bid Offer Files Schedule One
29th Sep 20238:00 amRNSHalf Yearly Report for period ending 30 June 2023
19th Sep 20237:00 amRNSMicroSalt Partnership with Weijohn Farms Group
13th Sep 20234:15 pmRNSNotification of Major Holdings
11th Sep 20237:00 amRNSInnovative Eyewear Announces Patent Filing
7th Sep 20237:00 amRNSMicroSalt files New Patent to Improve Baked Goods
6th Sep 20237:00 amRNSGuident Update
24th Aug 20237:00 amRNSPortfolio Company Update - Guident
17th Aug 20237:00 amRNSPortfolio Companies Update
14th Aug 20237:00 amRNSLucyd ChatGPT App Update for Smart Eyewear
1st Aug 20237:00 amRNSInnovative Eyewear Launches Lucyd Blueshift Lens
31st Jul 20237:00 amRNSMicroSalt commercial orders for SaltMe Crisps
30th Jun 20237:00 amRNSInnovative Eyewear Miami Fashion Week
28th Jun 20237:00 amRNSInnovative Eyewear Partnership with PRIVATO
26th Jun 20237:00 amRNSMicroSalt Expands U.S. Retail Network
22nd Jun 20231:38 pmRNSResults of Annual General Meeting
22nd Jun 20231:27 pmRNSInnovative Eyewear US$ 4.7Million Public Offering

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.